Research groups
Colleges
Websites
-
OCMR
Oxford Centre for Clinical Magnetic Resonance Research
-
BSCR
British Society for Cardiovascular Research
-
Novo Nordisk
Novo Nordisk (Funding)
Michael Dodd
DPhil, MBiochem, MRSB, FHEA
Novo Nordisk Postdoctoral Research Fellow
I am a Novo Nordisk Postdoctoral Researcher Fellow in Dr Lisa Heather's group in the Department of Physiology, Anatomy and Genetics, Oxford. I originally studied Biochemistry at Bath University, before working at Powdermed vaccines in Oxford. After that I came to the Department of Cardiovascular Medicine and the Department of Physiology, Anatomy and Genetics to study for my DPhil.
My research involves examining the metabolism of the failing and diseased heart. The healthy heart derives 60-80% of its energy from the burning of fat, the rest from carbohydrates and ketones. During heart disease this carefully balanced use of fuel can become breakdown.
We are using a host of techniques to understand changes in heart structure, function and metabolism during heart disease. One technique is hyperpolarized magnetic resonance spectroscopy to understand the change in metabolism in these diseased states (done in collaboration with Prof Tyler's group) and example of this can be seen in Figure 1. The focus of my fellowship involves understanding how cardiac metabolism is altered during both diabetes and hypoxia, using cardiac cells.
Recent publications
-
Bernard and Joan Marshall Awards at the autumn meeting of the British Society for Cardiovascular Research 2017
Journal article
Carr CA. et al, (2018), Heart
-
CPT1a-dependent long-chain fatty acid oxidation contributes to maintaining glucagon secretion from pancreatic islets
Journal article
Briant LJB. et al, (2018), Cell Reports
-
The 'Goldilocks zone' of fatty acid metabolism; to ensure that the relationship with cardiac function is just right.
Journal article
Kerr M. et al, (2017), Clinical science (London, England : 1979), 131, 2079 - 2094
-
Targeting hypoxia-inducible factor 1 (HIF-1) signalling in the Type 2 diabetic heart: dimethyloxaloylglycine (DMOG) improves functional recovery following ischaemia-reperfusion despite no change in glycolysis
Poster
Sousa Fialho MDL. et al, (2017), DIABETIC MEDICINE, 34, 49 - 49
-
Cardiac MRS Studies in Rodents and Other Animals
Chapter
Dodd MS. et al, (2016), Handbook of Magnetic Resonance Spectroscopy In Vivo MRS Theory, Practice and Applications
Mitochondria in HL-1 cardiomyocytes
